Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
The polymorphisms and haplotypes of Pin1 gene are associated with the risk of lung cancer 吕嘉春,赵红军,杨磊,刘斌,纪卫东,宾晓农 广州医学院 化学致癌研究所、呼吸疾病国家重点实验室 承国家自然科学基金项目(30200235、30371196、30671813、30872178)资助 Upstream signals Kinases Ser/Thr-Pro Mapks GSKs CDKs Phosphalases Ser/Thr-Pro p Ser/Thr-Pro PP2A Signaling transduction ras/Neu-Jun p53, p63, p73 Pin1 NF-κB Wnt/β-catenin Cancer BACKGROUND Lung cancer is one of the leading causes of death in the world, and so does in Guangzhou. The death rate of lung cancer in Guangzhou city was 11.61/105 during 1970-1972, increased to 32.67/105 during 1980-1982, to 41.54/105 during 1990-1992, and to 48.79/105 during 2000-2002. Pro-directed phosphorylation is an important signaling mechanism controlling diverse cellular processes, including cell-cycle progression, and cell proliferation and differentiation. The mechanisms controlling Pro-directed phosphorylation can result in cell transformation and oncogenesis. BACKGROUND Pin1 specifically regulates the conformation of Pro-directed phosphorylation sites. Pin1 substrates include many essential cancer-related proteins, such as von Hippel-Lindau tumor suppressor, myc, GSK -3 beta, cyclin D1, Cdc25, cdc2/cyclin B, p73, and p53. Aberrant over expressions of Pin1 have been reported in many cancers, including lung, breast and liver cancers. Inhibition of Pin1 in cancer cells can trigger apoptosis or suppress the transformed phenotype. Moreover, the Pin1 knockout -/- female mice showed impaired growth of mammary cells. The -842G>C polymorphism has been found to be associated with low risk of head neck and breast cancer in American white population. HYPOTHESIS The genetic variations in the promoter region of Pin1 gene and their possible interaction with environmental factors may play a role in the risk of lung cancer STUDY DESIGN The studied SNPs were selected based on the dbSNP database and re-sequencing data. A hospital-based case-control study 1056 newly diagnosed patients with sporadic lung cancer were recruited in Guangzhou. 1056 cancer-free controls were recruited from healthy subjects in the community health centers. The cases and controls frequency matched by age (±5 years) and sex All subjects were Chinese Han. Genomic structure of PIN1 gene GENOTYPING-PCR-RFLP Since the Pin1-842G>C (rs2233678) and -667T>C (rs2233679) are close in distance, we used one pair of primers 5’-CGG GCT CTG CAG ACT CTA TT -3’ (FP) 5’-AAA TTT GGC TCC TCC ATC CT -3’(RP) Restriction enzyme: BanII for -842G>C SacI for -667T>C -667TT Table I. Frequency distributions of selected variables in lung cancer cases and controls Variables Age (years) 60 > 60 Cases (n=1056) n % Controls (n=1056) n % pa 536 520 (50.8) (49.2) 534 522 (50.6) (49.4) 0.9306 746 310 (70.6) (29.4) 746 310 (70.6) (29.4) 1.0000 394 (37.3) 207 (19.6) 455 (43.1) a Two-sided 2 test; 366 176 514 (34.7) (16.7) (48.6) Sex male female Smoking current former never 0.0283 Table I. cont’ Cases (n=1056) Controls (n=1056) Variables Drinking current former never Family history n % n % 165 64 827 (15.6) (6.1) (78.3) 186 41 829 (17.6) (3.9) (78.5) pa 0.0429 0.9417 yes no BMI <18 18-25 >25 Sub-ethnic group TeoChewese(潮汕) Hakka (客家) Cantonese(广府) Other Hans(他省汉) 104 952 (9.9) (90.1) 103 953 (9.8) (90.2) 134 820 102 (12.7) (77.6) (9.7) 51 702 303 (4.8) (66.5) (28.7) <0.0001 90 198 683 85 (8.5) (18.8) (64.7) (8.0) 81 195 700 80 (7.7) (18.5) (66.3) (7.5) 0.8358 Table II. PIN1 genotypes and allele frequencies and logistic regression analysis for associations with lung cancer risk Genotypes -842G>C GG GC CC P trend GC+CC C allele -667C>T CC CT TT P trend CT+TT T allele Haplotypes G-T G-C C-T C-C Cases n (%) Controls n (%) 948(89.8) 103(9.7) 5(0.5) 895(84.7) 154(14.6) 7(0.7) 108(10.2) 0.053 161(15.3) 0.079 367 (34.7) 512 (48.5) 177 (16.8) 352 (33.3) 522 (49.4) 182 (17.3) 689 (65.3) 0.410 704 (66.7) 0.420 863(40.9) 1136(53.8) 39(1.8) 74(3.5) 832(39.4) 1112(52.6) 54(2.6) 114(5.4) Pa Crude OR (95% CI) Adjusted OR (95% CI) b 0.0025 1.00 (ref.) 0.63(0.48-0.83) 0.68(0.21-2.14) 0.0008 0.64(0.49-0.83) 1.00 (ref.) 0.64(0.48-0.84) 0.77(0.23-2.52) 0.0018 0.64(0.49-0.84) 1.00 (ref.) 0.94(0.78-1.14) 0.93(0.72-1.20) 0.6179 0.94(0.78-1.12) 1.00 (ref.) 0.89(0.73-1.08) 0.83(0.64-1.08) 0.6984 0.87(0.73-1.06) 1.00 (ref) 0.97(0.75-1.26) 0.50(0.17-1.49) 0.40(0.20-0.78) 1.00 (ref) 1.11(0.85-1.46) 0.64(0.21-1.95) 0.41(0.21-0.82) 0.0007 0.5132 0.5322 0.007 Two-sided 2 test for either genotype distribution or allele frequency. b Adjusted for age, sex, smoking status, and alcohol, family cancer history. a Table III. Stratification analysis of the PIN1 -842G>C genotypes in lung cancer cases and controls Patients (n = 1056) GG n (%) GC+CC n (%) Controls (n = 1056) Crude OR ( 95% CI) Adjusted OR ( 95% CI)a GC+CC vs GG GG n (%) GC+CC n (%) GC+CC vs GG Phomb Age (years) 60 485(90.5) 51(9.5) 455(85.2) 79(14.8) 0.61(0.42-0.88) 0.65(0.44-0.95) > 60 463(89.0) 57(11.0) 440(84.3) 82(15.7) 0.66(0.46-0.95) 0.63(0.43-0.92) Male 672(90.1) 74(9.9) 634(85.0) 112(15.0) 0.62(0.46-0.85) 0.62(0.45-0.86) Female 276(89.0) 34(11.0) 261(84.2) 49(15.8) 0.66(0.41-1.05) 0.71(0.43-1.16) Ever 540(89.9) 61(10.1) 452(83.4) 90(16.6) 0.57(0.40-0.80) 0.58(0.41-0.83) Never 408(89.7) 47(10.3) 443(86.2) 71(13.8) 0.72(0.49-1.06) 0.71(0.47-1.07) Ever 208(90.8) 21(9.2) 187(82.4) 40(17.6) 0.47(0.27-0.83) 0.50(0.28-0.92) Never 740(89.5) 87(10.5) 708(85.4) 121(14.6) 0.69(0.51-0.92) 0.69(0.51-0.93) 0.852 Sex 0.837 Smoking 0.407 Drinking 0.366 Table III. cont’ Patients (n = 1056) GG n (%) GC+CC n (%) Controls (n = 1056) GG n (%) GC+CC n (%) Crude OR ( 95% CI) GC+CC vs GG Adjusted OR ( 95% CI)a Phomb GC+CC vs GG Family history of cancer Yes 97(93.3) 7(6.7) 81(78.6) 22(21.4) 0.27(0.11-0.65) 0.29(0.11-0.74) No 851(89.4) 101(10.6) 814(85.4) 139(14.6) 0.70(0.53-0.91) 0.70(0.53-0.93) ≤23.9 126(94.0) 8(6.0) 44(86.3) 7(13.7) 0.40(0.14-1.16) 0.41(0.14-1.23) 24.0-27.9 730(89.0) 90(11.0) 593(84.5) 109(15.5) 0.67(0.50-0.91) 0.66(0.49-0.89) ≥28.0 92(90.2) 10(9.8) 258(85.1) 45(14.9) 0.62(0.30-1.29) 0.63(0.31-1.31) 0.047 BMI a b ORs were adjusted by age, sex, smoking, drinking, BMI and family history of cancer P value of the test for homogeneity between stratum-related ORs for Pin1-842 . 0.729 Luciferase assay: Pin1 -842 C variant decrease gene’s transcriptional activity G-T G-C C-T Luciferase activity (Relative level) C-C G-T G-C C-T C-C 350 300 250 200 150 100 50 0 A549 L78 All P<0.001 16HBE Population stratification • Multilevel Logistic regression null model: the sub-ethnic group to the risk of lung cancer OR=0.971,95%CI=0.862–1.094;P=0.6277 • Multilevel Logistic regression 2 level model: the sub-ethnic group as level 2, age, sex, smoking, drinking and Pin1-842G>C genotypes as level 1, Pin1-842G>C: OR=0.639, 95%C.I.=0.488–0.836; P=0.0011. After controlling the confounding effect of sub-ethnic groups, the main effect of Pin1-842G>C is still significant. False positive report probability (FPRP) for association between Pin1 -842 G>C polymorphism with lung cancer risk OR=0.64 (0.49-0.84), Power=0.927 null OR=0.67 (or 1/1.5) Prior probability =0.01 FPRP=0.06 → noteworthy at 0.2 level The finding of this study is unlikely by chance. CONCLUSION The functional genetic variant -842G>C of Pin1 gene contributes to decreased the risk of lung cancer by diminishing the promoter activity Limitations • Hospital-based, retrospective study. • Fewer SNPs were genotyped • Restricted to a Chinese Han population Acknowledgement Dr. Lu’s lab staff, GZMC Dr. Wei’s lab staff, UT MDACC Thanks for your attention ! 谢谢!